Johnson & Johnson received U.S. FDA investigational device exemption to begin the pivotal clinical trial for the Ottava robotic surgical system. If the trial goes well, Ottava could pose a significant challenge to decades-long dominance of the robotic surgical market by Intuitive Surgical Inc.’s Da Vinci system. Read More
Device makers are not necessarily fond of the need to acquire Medicare coverage by picking off one Medicare administrative contractor at a time, but Cleerly Labs Inc. worked this path with gusto. Read More
Cancer therapies can eliminate specific tumors based on their genetic content. However, some cancer cells survive. How do they do it? Part of the answer lies in extrachromosomal DNA (ecDNA), an ace up the tumors’ sleeve to adapt and evade attack. Three simultaneous studies in the journal Nature lay all the cards on the table, revealing ecDNAs’ content, their origin, their inheritance, their influence in cancer, and a way to combat them. Read More
Med-tech firms raising money in public or private financings, including: Debx Medical, Glucotrack, Medeloop, Metasight Diagnostics, QT Imaging. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Avita, Heartsciences, ICU Medical, Lunit, Mainz Biomed, Otsuka, Qiagen, QT Imaging, Shineco, Vidi. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Fourth Frontier, GE Medical, Med-El, Smartcardia. Read More
